Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 265

1.

Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high-responding inhibitors.

Coppola A, Margaglione M, Santagostino E, Rocino A, Grandone E, Mannucci PM, Di Minno G; AICE PROFIT Study Group.

J Thromb Haemost. 2009 Nov;7(11):1809-15. doi: 10.1111/j.1538-7836.2009.03615.x. Epub 2009 Sep 9.

2.

Immune tolerance induction with recombinant factor VIII in hemophilia A patients with high responding inhibitors.

Rocino A, Santagostino E, Mancuso ME, Mannucci PM.

Haematologica. 2006 Apr;91(4):558-61.

3.

F8 gene mutation profile and ITT response in a cohort of Italian haemophilia A patients with inhibitors.

Salviato R, Belvini D, Radossi P, Sartori R, Pierobon F, Zanotto D, Zanon E, Castaman G, Gandini G, Tagariello G.

Haemophilia. 2007 Jul;13(4):361-72.

PMID:
17610549
4.

Low-dose immune tolerance induction for paediatric haemophilia patients with factor VIII inhibitors.

Unuvar A, Kavakli K, Baytan B, Kazanci E, Sayli T, Oren H, Celkan T, Gursel T.

Haemophilia. 2008 Mar;14(2):315-22. Epub 2007 Dec 10.

PMID:
18081830
5.

Immune tolerance induction with a high purity von Willebrand factor/VIII complex concentrate in haemophilia A patients with inhibitors at high risk of a poor response.

Gringeri A, Musso R, Mazzucconi MG, Piseddu G, Schiavoni M, Pignoloni P, Mannucci PM; RITS-FITNHES Study Group.

Haemophilia. 2007 Jul;13(4):373-9.

PMID:
17610550
6.
8.

F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis.

Gouw SC, van den Berg HM, Oldenburg J, Astermark J, de Groot PG, Margaglione M, Thompson AR, van Heerde W, Boekhorst J, Miller CH, le Cessie S, van der Bom JG.

Blood. 2012 Mar 22;119(12):2922-34. doi: 10.1182/blood-2011-09-379453. Epub 2012 Jan 26. Review.

9.

Influence of the type of F8 gene mutation on inhibitor development in a single centre cohort of severe haemophilia A patients.

Gouw SC, Van Der Bom JG, Van Den Berg HM, Zewald RA, Ploos Van Amstel JK, Mauser-Bunschoten EP.

Haemophilia. 2011 Mar;17(2):275-81. doi: 10.1111/j.1365-2516.2010.02420.x. Epub 2010 Nov 11.

PMID:
21070499
10.

Factor VIII genotype and inhibitor development in patients with haemophilia A: highest risk in patients with splice site mutations.

Boekhorst J, Lari GR, D'Oiron R, Costa JM, Nováková IR, Ala FA, Lavergne JM, VAN Heerde WL.

Haemophilia. 2008 Jul;14(4):729-35. doi: 10.1111/j.1365-2516.2008.01694.x. Epub 2008 May 12.

PMID:
18503540
11.

The Italian AICE-Genetics hemophilia A database: results and correlation with clinical phenotype.

Margaglione M, Castaman G, Morfini M, Rocino A, Santagostino E, Tagariello G, Tagliaferri AR, Zanon E, Bicocchi MP, Castaldo G, Peyvandi F, Santacroce R, Torricelli F, Grandone E, Mannucci PM; AICE-Genetics Study Group.

Haematologica. 2008 May;93(5):722-8. doi: 10.3324/haematol.12427. Epub 2008 Apr 2.

12.

Factor 8 (F8) gene mutation profile of Turkish hemophilia A patients with inhibitors.

Fidanci ID, Kavakli K, Uçar C, Timur C, Meral A, Kilinç Y, Sayilan H, Kazanci E, Cağlayan SH.

Blood Coagul Fibrinolysis. 2008 Jul;19(5):383-8. doi: 10.1097/MBC.0b013e3282f9b193.

PMID:
18600086
13.

New protocol for immune tolerance induction in acquired hemophilia.

Nemes L, Pitlik E.

Haematologica. 2000 Oct;85(10 Suppl):64-8.

PMID:
11187874
14.

Immune tolerance induction for the eradication of inhibitors in patients with hemophilia A.

Kruse-Jarres R, Barnett B, Leissinger C.

Expert Opin Biol Ther. 2008 Dec;8(12):1885-96. doi: 10.1517/14712590802515537 . Review.

PMID:
18990076
15.

Successful low dose immune tolerance induction in severe haemophilia A with inhibitors below 40 Bethesda Units.

Ter Avest PC, Fischer K, Gouw SC, Van Dijk K, Mauser-Bunschoten EP.

Haemophilia. 2010 May;16(102):71-9. doi: 10.1111/j.1365-2516.2010.02225.x.

PMID:
20536988
16.
17.

Immune tolerance: critical issues of factor dose, purity and treatment complications.

DiMichele DM.

Haemophilia. 2006 Dec;12 Suppl 6:81-5; discussion 85-6. Review.

PMID:
17123399
19.

Immune tolerance in hemophilia with factor VIII inhibitors: predictors of success.

Mariani G, Kroner B; Immune Tolerance Study Group (ITSG).

Haematologica. 2001 Nov;86(11):1186-93.

20.

The incidence of inhibitor development according to specific mutations--and treatment?

Goodeve A.

Blood Coagul Fibrinolysis. 2003 Jun;14 Suppl 1:S17-21. Review.

PMID:
14567530
Items per page

Supplemental Content

Write to the Help Desk